Session — ASN Events
clear
Aromatase expression is inhibited by tumour suppressor p53 and PGE2 down regulates p53 in breast tumour associated adipose stromal cells A novel Heme oxygenase-1 inducer decreases sFlt1 production in primary placental and endothelial cells: may provide therapeutic options for preeclampsia. Craniopharyngiomas and wingless cascade signaling Sex-specific placental and fetal phenotypes in bovine at Midgestation Bone mineral density in a cohort of patients with phaeochromocytoma and paraganglioma Egg fertilisation in Japanese quail is independent of sperm motility traits Genes regulating antigen-presenting cell phenotype are dysregulated in the eutopic endometrium of women with endometriosis. Sex steroid moduation of growth hormone action Circadian variation in pregnancy: consequences for maternal adaptation, placental function and the response to obesity Can neonatal exendin-4 prevent obesity after IUGR? Cortical bone fragility contributes to fractures in children L-Proline transporters in the pre-implantation mouse embryo Toll-like receptor 4 signalling in inflammation pathways to term and preterm delivery. Dual-mode regulation of the APC by CDK1 and MAPK is important for the progression and fidelity of meiosis I Identification of Castration-Tolerant Repopulating Cells in Localised Prostate Cancer Tissues Inhibition of the TLR4 signalling pathway protects from LPS-induced pre-term delivery Pas de deux: Chromatin binding of androgen and estrogen receptors in breast cancer Genomic Imprinting in health and disease Vitamin D measurements 15 minutes of fame The placenta and pregnancy outcome Effects of energy restriction on neuroendocrine status in obese adults, and possible effects on body composition and strength Oxytocin in Psychiatry Persistent chlamydial infection in the testes: a hidden cause of male subfertility Neuroendocrine modulation of growth hormone (GH) secretion: Integrating the secretion of GH relative to positive and negative energy balance. Prolactin, progesterone and their role in estrogen resistant breast cancer